Bank of America
HOWL icon

Bank of America’s Werewolf Therapeutics HOWL Stock Holding History

Bank of America’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Sell
264,583
-472,967
-64% -$324K ﹤0.01% 5319
2025
Q4 		$467K Sell
737,550
-1,092,742
-60% -$1.33M ﹤0.01% 4945
2025
Q3 		$3.61M Sell
1,830,292
-298,732
-14% -$409K ﹤0.01% 4319
2025
Q2 		$2.32M Buy
2,129,024
+25,882
+1% +$26.6K ﹤0.01% 4645
2025
Q1 		$2.04M Buy
2,103,142
+24,267
+1% +$31.8K ﹤0.01% 4665
2024
Q4 		$3.08M Sell
2,078,875
-74,842
-3% -$153K ﹤0.01% 4064
2024
Q3 		$4.57M Buy
2,153,717
+6,292
+0.3% +$14.3K ﹤0.01% 3816
2024
Q2 		$5.24M Buy
2,147,425
+266,312
+14% +$1.28M ﹤0.01% 3578
2024
Q1 		$12.2M Sell
1,881,113
-214,968
-10% -$1.25M ﹤0.01% 2786
2023
Q4 		$8.09M Buy
2,096,081
+564,157
+37% +$1.44M ﹤0.01% 3106
2023
Q3 		$3.28M Buy
1,531,924
+2,069
+0.1% +$5.7K ﹤0.01% 3789
2023
Q2 		$4.67M Sell
1,529,855
-1,608
-0.1% -$4.53K ﹤0.01% 3478
2023
Q1 		$3.98M Sell
1,531,463
-2,129
-0.1% -$6.35K ﹤0.01% 3739
2022
Q4 		$3.14M Buy
1,533,592
+1,530,114
+43,994% +$4M ﹤0.01% 3838
2022
Q3 		$15K Buy
3,478
+784
+29% +$4.26K ﹤0.01% 7122
2022
Q2 		$11K Sell
2,694
-19,623
-88% -$89.5K ﹤0.01% 7363
2022
Q1 		$98K Sell
22,317
-5,948
-21% -$41.7K ﹤0.01% 6877
2021
Q4 		$337K Buy
28,265
+27,646
+4,466% +$417K ﹤0.01% 6164
2021
Q3 		$11K Buy
619
+132
+27% +$2.25K ﹤0.01% 7547
2021
Q2 		$8K Buy
+487
New +$6.67K ﹤0.01% 7348

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bank of America's HOWL Position: Q1 2026 in Review

Bank of America reduced its Werewolf Therapeutics (HOWL) stake by 64% in Q1 2026, selling an estimated $324K and leaving 264,583 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #5319.

Bank of America first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $12.2M in Q1 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Bank of America held 264,583 shares of Werewolf Therapeutics worth $220K as of Q1 2026.
  • Bank of America sold 472,967 Werewolf Therapeutics shares in Q1 2026, an estimated $324K.
  • Werewolf Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5319 holding.
  • Bank of America first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Werewolf Therapeutics position peaked at $12.2M in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.